SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

ORMP

ORAMED PHARMACEUTICALS INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 8h ago SEC0001493152-26-051853
Passive stake amendment
Actionable Insight • Neutral

Aquamarine is a new 5%+ passive holder. Monitor for any future conversion to 13D (activist intent) or further stake changes. The passive certification limits near-term activist risk.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Aquamarine Financial (Cayman) Ltd filed an amended Schedule 13G disclosing a 6.38% passive stake in Oramed Pharmaceuticals as of September 30, 2026, representing 2,653,567 shares. This is a new filing by this investor; no prior stake was disclosed by Aquamarine in the cross-filing context, so this is an initial entry above the 5% threshold.

Key Financial Metrics

Stake
6.38%
Investor
Aquamarine Financial (Cayman) Ltd

Key Facts

  • Aquamarine Financial (Cayman) Ltd reported beneficial ownership of 2,653,567 shares of Oramed Pharmaceuticals common stock.
  • The stake represents 6.38% of shares outstanding as of September 30, 2026.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
  • No prior filings by Aquamarine appear in the cross-filing context; this is the first disclosure above 5% by this entity.

Financial Impact

6.38% stake valued at approximately $11M based on $172M market cap

ownership concentration

Risk Factors

  • Passive holder could later convert to activist (13D) or reduce stake below 5%.
  • No financial data or business updates in this filing; limited read-through for fundamentals.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001493152-26-051853
Document: 0001493152-26-051853-index.html0001493152-26-051853
Document: 0001493152-26-051853.txt0001493152-26-051853

Track record

4 reports on ORMP

Performance horizon
Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $4.03 Now $3.90 −3.23% settles Dec 15
  2. Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $4.55 to $4.11 Now $3.90 −14.29% ▼ −9.67% −7.20% vs SPY
  3. Jul 2, 202619w ago Insider Cluster Neutral 4/10 Entry $4.60 to $4.12 Now $3.90 −15.22% ▼ −10.43% −10.02% vs SPY
  4. Jun 30, 202619w ago 8-K Mixed 5/10 Entry $4.61 to $3.97 Now $3.90 −15.40% ▼ −13.88% −11.70% vs SPY
Showing 4 of 4

US Market Status

Market Closed · Opens in 7h 16m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026